Randal
Otto, MD

Dr. Randal Otto is the chair of the department of otolaryngology. His clinical and research interests are in head and neck oncology, diseases of the thyroid and parathyroid, reconstructive head and neck surgery, paranasal sinus disease, and cancers of the tongue, throat, tonsil, larynx, pharynx, neck,skin, paranasal sinuses and ear.
Publications
French, J.T., Goins, B., Saenz, M., Li, S., Garcia-Rojas, X., Phillips, W.T., Otto, R.A. & Bao, A. Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide. J Vasc Interv Radiol. 21(8):1271-9 (2010). PMCID:PMC2910224
Hrycushko, B. A., Li, S., Goins, B., Otto, R. A. & Bao, A. Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution. Med. Phys. 38(3):1339-47 (2011). PMID:21520844; PMCID:PMC3055907
Wang, S.X., Bao, A., Phillips, W.T., Goins, B., Herrera, S.J., Santoyo, C., Miller, F.R. & Otto, R.A. Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model. Int J Pharm. 373(1-2):156-64 (2009). PMID:19429301

• Dr. Randal Otto named to new leadership position at CTRC
• UT Medicine San Antonio places faculty on top doctors lists
• UT Medicine physicians recognized as Best Doctors in America®
• San Antonio Life Sciences Institute funds 1st projects
• Novel therapy delivers radioactive lipid nanospheres to tumors
• Laredo area foundations support UT Health Science Center programs
• Book describes advances in imaging of drug-delivery nanoparticles
• Anti-pain agent shrinks oral cancers, leaves healthy tissues alone